🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Humanoids are finally ready for the real world. But can they work alongside our specialized robots to transform pharma manufacturing? Join Tony Yang from Unitree and me on Cell Mates, Multiply Labs’s podcast to find out! The Episode drops in April!

People think pharma automation is still years out. But Multiply Labs is already doing it—replacing human touchpoints (the #1 source of contamination and low yields) with robots that don’t get tired, make mistakes, or … well, get bored 🦾. As cutting-edge therapies get more

🤖 Big milestone! Multiply Labs has joined the NVIDIA Inception Program. 🚀 Excited to leverage NVIDIA's AI power to scale our robotic manufacturing of next-gen therapies. The future of biomanufacturing is robotic! #nvidiainception #robotics #AI #biomanufacturing

Some say that the pinnacle of robotics is the humanoid form. But the true potential of robotics lies in transcending this assumption, and achieving super-human performance. It turns out that such a robotic system does not "just" have one arm, or two, but FOUR - and that’s not

How many robotic arms are in this video? Answer: 4! In <100 sq ft! That's a record for high-efficiency, high-throughput biomanufacturing! Multiply Labs' robotic systems transcend the limits of the human form, to achieve superhuman manufacturing performance. Imagine how many

Robotic automation helps address one of the biggest bottlenecks in the next-gen therapy market - namely, how to scale manufacturing processes. The next natural question is: how do we scale our robotic manufacturing technology to as many next-gen therapies as possible? Our

Can robots match trained human precision in cell therapy manufacturing? According to our latest study: yes! This is the first side-by-side comparison of robotic vs. human execution of key bioprocessing steps 📖 Read: biorxiv.org/content/10.110… 🎥 Watch: Below to see it in action!

We strapped a Go-Pro onto our new robots to show you what it looks like from their perspective - clean, repeatable, and automated! Here you see a bag get loaded into an industry-standard incubator, completely autonomously. The future of biomanufacturing is robotic! #robotics

We're proud to share that Multiply Labs has been featured in the latest issue of Cell & Gene Therapy Insights! Read the article: insights.bio/cell-and-gene-… Our Co-Founder & CEO, Fred Parietti, discussed the transformative impact of automation in scaling advanced cell and gene

In high-performance computing, even the fastest CPUs sit idle waiting on disk or network I/O—wasting precious cycles and capping performance. The same holds true in robotic biomanufacturing: continuous operation of a high-throughput cluster demands seamless and rapid input and

As we scaled the throughput of our robotic systems at Multiply Labs, we realized that wherever there are humans performing repetitive tasks, that always eventually becomes the bottleneck. Watch our engineering journey below in our first ever "Lab Notes" style video!

Happy to announce that we have formally moved into our new HQ in the heart of the vibrant San Francisco Dogpatch District! Our expanded space marks an exciting chapter as we scale up our robotic vision for biomanufacturing, enabling widespread patient access to therapies that

At Multiply Labs, we've redefined biomanufacturing from first principles—standardizing fundamental "unit operations" for scalable, seamless automation. Check out our unit operations in action, and reach out at [email protected] to learn more! #robotics #biomanufacturing

At Multiply Labs, we’re building the robotic future of biomanufacturing—but behind every robot action is a team of brilliant individuals making it all possible. Nadia, our head of Robotics Software, together with Varun, Nicole, and Justin are just a few of our robotic software

Humanoid robots have always captured the imagination. But what happens when we move beyond science fiction—and into the cleanroom? In Episode 2 of Cell Mates, we’re joined by Tony Yang, Director of North American Markets at Unitree Robotics, to explore the real-world potential